Loading…
Held by 3 funds across 3 fund houses in our coverage.
Coverage: 22 of India's largest fund houses — growing.
As of the latest monthly AMC disclosures, Windlas Biotech is held by 3 mutual funds and ETFs in our database. The total value of equity held across these schemes is ₹67 Cr. Among all holding funds, the manager with the highest conviction is UTI - Healthcare Fund (UTI MF), which allocates a significant 1.17% of its entire portfolio to Windlas Biotech.
In terms of category distribution, Sectoral / Thematic funds hold the largest exposure by market value, representing 2 positions. Across different fund houses, ICICI Pru MF manages the largest aggregate stake, holding a combined value of ₹51 Cr. This distribution indicates whether the stock is favored by active diversified equity managers or is primarily held in sector-specific/thematic portfolios.
| # | Rank | ||||
|---|---|---|---|---|---|
| 1 | UTI - Healthcare FundUTI MFSectoral / Thematic₹15.99 Cr | 1.17% | ₹15.99 Cr | 1.86 L | #33 of 43 |
| 2 | ICICI Prudential Pharma Healthcare and Diagnostics FundICICI Pru MFSectoral / Thematic₹51.30 Cr | 0.75% | ₹51.30 Cr | 5.98 L | #30 of 35 |
| 3 | Back to IndexMotilal Oswal MFIndex Fund₹1.84 L | 0.04% | ₹1.84 L | 215 | #102 of 125 |
Portfolios as on: UTI MF Jul 2026 · ICICI Pru MF Jul 2026 · Motilal Oswal MF Jul 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).